Yu Chieh (Peter) Wang M.D
About Yu Chieh (Peter) Wang M.D
Yu Chieh (Peter) Wang M.D. is the Project Management & Business Development Office Lead at Bristol Myers Squibb Taiwan, with extensive experience in oncology, immunology, and business development.
Title and Current Position
Yu Chieh (Peter) Wang M.D serves as the BMS Taiwan Project Management & Business Development Office Lead at Bristol Myers Squibb. Based in Taipei City, Taiwan, he manages and leads a team focusing on various strategic projects and initiatives.
Previous Roles at Bristol Myers Squibb
Before his current role, Yu Chieh (Peter) Wang M.D held several key positions at Bristol Myers Squibb. From 2020 to 2021, he was the BMS Taiwan External Innovation Lead/Innovative Medicine Disease Area Lead. Prior to that, he served as the Immuno-Oncology Disease Area Lead from 2019 to 2020. In these roles, he was instrumental in driving innovation and overseeing disease area strategies in Taiwan.
Experience at MSD
Yu Chieh (Peter) Wang M.D worked at MSD as a Medical Advisor for Oncology from 2017 to 2018. He also held the position of Immuno-Oncology MSL from 2015 to 2017. During his tenure at MSD, he contributed to the medical strategy and played a critical role in the early and late phases of drug development.
Educational Background
Yu Chieh (Peter) Wang M.D earned his Doctor of Medicine (M.D.) from Tzu Chi University, where he studied from 2004 to 2012. He also completed his high school education at Ruamrudee International School in Bangkok, Thailand, from 2000 to 2004, achieving his High School Diploma.
Responsibilities at Bristol Myers Squibb
In his current role, Yu Chieh (Peter) Wang M.D leads the search and evaluation of external innovation and business development opportunities at BMS Taiwan. He is a member of the BMS Taiwan country lead team, focusing on enterprise-level projects such as new product planning and mature product life cycle management. Additionally, he manages external corporate affairs initiatives and oversees project management of leadership and culture initiatives to build a high-performance team.
Broad Expertise in Therapeutic Areas
Yu Chieh (Peter) Wang M.D has a substantial background in multiple therapeutic areas, including virology, immunology, neuroscience, gastroenterology, and dermatology. He has comprehensive experience in the full cycle of oncology new drug development, from early phase studies to post-launch medical and marketing activities.